← Evidence map

ReviewMelanoma management2016

Combination or single-agent ipilimumab as immunotherapy of advanced melanoma: a critical review.

Omar Abdel-RahmanPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2016
2017
2018
2019
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 30190892